HDAC1 and cancer: However, intracellular S1P may also promote cancer progression via intracellular targets, such as HDAC1/2 [82] and NF-κB [83], and can promote cancer cell resistance to therapy by counteracting the pro-apoptotic effects of ceramide [84].